Profund Advisors LLC Novo Nordisk A S Transaction History

Profund Advisors LLC

$2.59 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$90.94 - $199.54 $574,377 - $1.26 Million	6,316 Added 88.82%	13,427 $1.22 Million
Q2 2023 Aug 10, 2023	SELL	$155.98 - $172.65 $212,288 - $234,976	-1,361 Reduced 16.06%	7,111 $1.15 Million
Q1 2023 May 11, 2023	BUY	$132.34 - $159.14 $85,623 - $102,963	647 Added 8.27%	8,472 $1.35 Million
Q4 2022 Feb 02, 2023	BUY	$102.55 - $135.33 $134,237 - $177,146	1,309 Added 20.09%	7,825 $1.06 Million
Q3 2022 Nov 04, 2022	SELL	$95.28 - $116.93 $69,935 - $85,826	-734 Reduced 10.12%	6,516 $649,000
Q2 2022 Aug 01, 2022	SELL	$103.24 - $121.81 $69,480 - $81,978	-673 Reduced 8.49%	7,250 $808,000
Q1 2022 May 10, 2022	SELL	$93.1 - $112.54 $4,096 - $4,951	-44 Reduced 0.55%	7,923 $880,000
Q4 2021 Feb 08, 2022	SELL	$95.88 - $117.08 $558,692 - $682,225	-5,827 Reduced 42.24%	7,967 $892,000
Q3 2021 Nov 12, 2021	BUY	$84.42 - $106.62 $48,625 - $61,413	576 Added 4.36%	13,794 $1.32 Million
Q2 2021 Aug 12, 2021	BUY	$67.66 - $84.76 $24,019 - $30,089	355 Added 2.76%	13,218 $1.11 Million
Q1 2021 May 14, 2021	BUY	$67.06 - $75.82 $30,445 - $34,422	454 Added 3.66%	12,863 $867,000
Q4 2020 Feb 09, 2021	BUY	$63.89 - $73.8 $22,680 - $26,199	355 Added 2.95%	12,409 $867,000
Q3 2020 Nov 13, 2020	SELL	$63.69 - $70.22 $142,156 - $156,731	-2,232 Reduced 15.62%	12,054 $837,000
Q2 2020 Aug 03, 2020	BUY	$58.54 - $67.94 $151,735 - $176,100	2,592 Added 22.17%	14,286 $935,000
Q1 2020 May 15, 2020	SELL	$49.46 - $64.78 $177,264 - $232,171	-3,584 Reduced 23.46%	11,694 $704,000
Q4 2019 Feb 18, 2020	SELL	$49.86 - $58.26 $86,207 - $100,731	-1,729 Reduced 10.17%	15,278 $884,000
Q3 2019 Nov 12, 2019	SELL	$47.54 - $53.43 $108,058 - $121,446	-2,273 Reduced 11.79%	17,007 $879,000
Q2 2019 Aug 13, 2019	BUY	$46.79 - $52.47 $12,726 - $14,271	272 Added 1.43%	19,280 $984,000
Q1 2019 May 15, 2019	BUY	$46.36 - $52.63 $144,318 - $163,837	3,113 Added 19.58%	19,008 $994,000
Q4 2018 Feb 14, 2019	BUY	$41.54 - $47.25 $660,278 - $751,038	15,895 New	15,895 $732,000

Others Institutions Holding NVO

# of Institutions

1,955

Shares Held

318M

Call Options Held

5.49M

Put Options Held

7.78M

Jennison Associates LLC

20.2M
Shares

$1.73 Billion
1.5% of portfolio
Morgan Stanley New York, NY

14.4M
Shares

$1.23 Billion
0.13% of portfolio
Bank Of America Corp Charlotte, NC

14.3M
Shares

$1.23 Billion
0.14% of portfolio
Ken Fisher Fisher Asset Management, LLC | Camas, Wa

13.3M
Shares

$1.14 Billion
0.65% of portfolio
Fayez Sarofim & CO Houston, TX

12.2M
Shares

$1.05 Billion
3.76% of portfolio

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $193B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Account